Tongshu Gene

China
Chonglou, Guangdong, China

Company profile

Tongshu Gene company profile

Tongshu Gene is a high-tech enterprise that focuses on the field of tumor precision medicine. The company provides gene testing services and develops diagnostic molecular pathology projects and ctDNA precision detection systems based on high-throughput gene sequencing technology and biological information analysis to provide clinicians with consulting services including precision medication, efficacy monitoring, postoperative recurrence monitoring, and risk prediction and early detection.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
2
Total equity funding
$92.2M
Last funding
Series D / $14.1M / 2024-10-14
Last equity funding
Series D / $14.1M
Investors
6
Lead investors
3

Founders and investors

Lead investors

Broad Vision FundsGL CapitalOceanpine Capital

Investors

Broad Vision FundsEverest Venture CapitalGL CapitalJiangsu Tuobang InvestmentOceanpine Capital